KalshiVérifier la disponibilitéKYC requis2% de fraisDonnées de résolution vérifiéesAssez bien calibréProbabilité implicite actuelle
COVID-19 14%En tête parmi 6 options
Qualité du marché
52 / 100
Qualité moyenneVolume 24h
0,9 €
Liquidité
5,1 k €
Liquidité moyenneÉcart
2.0 pt
Spread serréDonnées du marché
Mis à jour il y a 11 minutes
27 janv. 26, 01:00 UTC1 janv. 27, 15:00 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
The anti-vax market: Which vaccines become less available in the US, 2025-2026
Manifold MarketsWill GiveWell recommend a grant to support breastfeeding promotion before 2027?
Manifold MarketsWill FDA approve more than 10 new mRNA based vaccines before 2028?
Manifold MarketsMeasles cases in U.S. in 2026?
PolymarketNew pandemic in 2026?
PolymarketHantavirus pandemic in 2026?
PolymarketRègles
If the CDC ends its recommendation completely for the COVID-19 vaccine before Jan 1, 2027, then the market resolves to Yes.
Règlement via:CDC
- Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criterion.
- If the CDC ends its recommendation completely for the Dengue vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the the named outcome vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the Influenza vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the Polio vaccine before Jan 1, 2027, then the market resolves to Yes.
Marchés ouverts
Health & MedicinePOLYMARKETMeasles cases in U.S. in 2026?
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
- ↑2k+0.2pt100%
+9 résultats de plus
- Volume total
- 6,9 M €
- Volume 24h
- 28,1 k €
POLYMARKETHantavirus pandemic in 2026?
- No97%
- Yes3%
- Volume total
- 15,8 M €
- Volume 24h
- 21,5 k €
POLYMARKETNew pandemic in 2026?
- No-0.5pt93.1%
- Yes+0.5pt6.9%
- Volume total
- 944,9 k €
- Volume 24h
- 8,2 k €
KALSHIWhich countries will report an Ebola disease case before October?
- Kenya14%
- India6%
- Ethiopia-2.0pt5%
+13 résultats de plus
- Volume total
- 22,4 k €
- Volume 24h
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 600061%
+2 résultats de plus
- Volume total
- 882,9 k €
- Volume 24h
- 1,7 k €
KALSHIWill 3 mg THC beverages qualify as hemp under federal law?
- On Nov 13, 202696%
- On Mar 13, 202789%
- On Nov 19, 202786%
+1 résultats de plus
- Volume total
- 16,3 k €
- Volume 24h
- 1,3 k €
- Will 3 mg THC beverages be federally legal to sell?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- When will the FDA approve Compass Pathways' COMP360 Psilocybin?
- Cyclosporiasis cases reported in the US in 2026?
- Pandemic in 2026?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Hantavirus vaccine in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- FDA approves skin cancer vaccine by which date?
- How many gonorrhea cases will be reported in the United States in 2026?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Which vaccines will the CDC no longer recommend in 2026? ?
- Kalshi cote COVID-19 à 14% au 15 septembre 2026.
- Quand Which vaccines will the CDC no longer recommend in 2026? sera-t-il résolu ?
- Which vaccines will the CDC no longer recommend in 2026? doit être résolu le 1 janvier 2027.
- Comment Which vaccines will the CDC no longer recommend in 2026? est-il réglé ?
- Kalshi règle ce marché comme suit : If the CDC ends its recommendation completely for the COVID-19 vaccine before Jan 1, 2027, then the market resolves to Yes.